Abeona Therapeutics Inc (ABEO) — Cash Flow Quality Index
Abeona Therapeutics Inc (ABEO) has a Cash Flow Quality Index of -0.17x as of June 2025. Operating cash flow of $-18.78 Million is below net income of $108.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Abeona Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Abeona Therapeutics Inc Cash Flow Quality Index (1995–2025)
Historical Cash Flow Quality Index for Abeona Therapeutics Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ABEO operating cash flow.
Annual Cash Flow Quality Index for Abeona Therapeutics Inc (1995–2025)
Year-by-year earnings quality comparison for Abeona Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -1.07x | $-76.33 Million | $71.18 Million | ▼ -477144.2% |
| 2013 | 0.00x | $1.00K | $4.45 Million | ▼ -100.0% |
| 1995 | 1.93x | $658.00K | $341.00K | — |